Slide seminar on Cardiothoracic Pathology - IAPM Kerala 73rd meeting.
aarti iapm
-
Upload
neeraj-bhardwaj -
Category
Documents
-
view
231 -
download
0
Transcript of aarti iapm
-
8/8/2019 aarti iapm
1/60
-
8/8/2019 aarti iapm
2/60
ROE
ROE = net income/total stockholders equity =
Profit margin x Asset turnover x Equity multipl
-
8/8/2019 aarti iapm
3/60
-
8/8/2019 aarti iapm
4/60
PROFIT MARGIN
lier PAT ASSETS
SALES ASSESTS EQUITY
0.053 1.56 2.26
ROE 0.18
ASSSETTURNOVER
EQUITYMULTIPLIER
SALES
-
8/8/2019 aarti iapm
5/60
2014E 2015E 2016E 2017E 2018E
33.48 36.58 39.96 43.66 47.69
717.51
49.74 59.69 71.62 85.95 765.20
0.64 0.57 0.51 0.45 0.40
31.63 33.90 36.33 38.93 309.51
Y MATRIX( price / share )
9% 9.50% 10% 11% 12.00% 13%
371.90 336.30 305.33 254.03 213.20 179.88
397.98 357.95 323.51 267.20 223.04 187.41
428.80 383.21 344.48 282.12 234.03 195.73
465.78 413.06 368.94 299.18 246.40 204.97
510.99 448.88 397.86 318.86 260.42 215.30
567.50 492.66 432.55 341.83 276.44 226.93
640.15 547.39 474.90 368.97 294.92 240.10
-
8/8/2019 aarti iapm
6/60
-
8/8/2019 aarti iapm
7/60
Industry - Pharmaceuticals - Indian - Bulk [Rs. in Crs.]
Latest 2010
No. of Companies 129 14
16,166.59 8,638.27404.01 120.4
15,762.58 8,517.87
1,646.78 1,225.54
252.2 -151.91
17,661.56 9,591.50
8,108.35 3,925.31
596.53 393.75
1,178.19 805.44
1,290.10 433.69
1,791.72 1,177.96
851.13 354.4
1.3 0
13,814.72 7,090.55
3,846.84 2,500.95872.25 442.78
2,974.59 2,058.17661.26 394.22
2,313.33 1,663.95
318.86 166.34
12.34 0
125 98.07
1,857.13 1,399.54999.48 889.19
857.65 510.357.26 2.44
2,852.39 1,874.21
0 0
1,216.71 869.38
3,500.07 2,406.81
566.59 318.91
0 0
Year
INCOME :
Sales TurnoverExcise Duty
Net Sales
Other Income
Stock Adjustments
Total IncomeEXPENDITURE :
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Administration Expenses
Miscellaneous Expenses
Less: Pre-operative Expenses Capitalised
Total Expenditure
Operating ProfitInterest
Gross ProfitDepreciation
Profit Before Tax
Tax
Fringe Benefit tax
Deferred Tax
Reported Net ProfitExtraordinary Items
Adjusted Net ProfitAdjst. below Net Profit
P & L Balance brought forward
Statutory Appropriations
Appropriations
P & L Balance carried down
Dividend
Preference Dividend
-
8/8/2019 aarti iapm
8/60
2009 2008 2007 2006
56 66 65 68
13,930.68 ### 9,762.44 8,050.73385.09 437.65 368.74 317.46
13,545.59 12,192.90 9,393.70 7,733.27
403 528.7 867.55 306.87
543.51 362.05 403.66 181.77
14,492.10 ### ### 8,221.91
7,068.58 6,225.27 5,290.36 4,281.08
514.29 458.95 365.05 298.16
972.82 797.19 644.78 519.66
1,181.45 1,019.66 483.95 387.35
1,432.84 1,278.96 1,066.15 863.06
680.57 449.5 191.74 161.04
0 0 0 0
11,850.55 10,229.53 8,042.03 6,510.35
2,641.55 2,854.12 2,622.88 1,711.56587.53 377.74 326.15 302.81
2,054.02 2,476.38 2,296.73 1,408.75517.48 444.36 375.08 322.44
1,536.54 2,032.02 1,921.65 1,086.31
213.32 280.17 224.53 195.03
31.29 25.46 20.24 19.12
48.32 84.45 47.95 35.79
1,243.61 1,641.94 1,628.93 836.3718.75 133.09 453.55 7.65
1,224.86 1,508.85 1,175.38 828.7212.59 18.06 3.13 -5.13
3,149.95 2,302.96 1,190.62 804.35
0 0 0 0
819.93 904.7 592.03 450.03
3,586.22 3,058.26 2,230.65 1,185.56
412.91 340.63 143.23 111.36
0 0.47 0.75 0.27
-
8/8/2019 aarti iapm
9/60
PRODUCTION
Year Bulk Drugs( Growth (%) EXPORT import
1985-86 416 10.3 33.36 208.13
1986-87 458 10.2 87.16 207.49
1987-88 480 4.6 139.71 234.13
1988-89 550 14.6 242.87 328.35
1989-90 640 16.4 350.5 425.64
1990-91 730 14.1 413.4 322.57
1991-92 900 23.3 722.6 458.51
1992-93 1150 27.8 856.6 508.39
1993-94 1320 14.8 1009.6 612.74
1994-95 1518 15 1260.7 811.43
1995-96 1822 20 1132.9 1,630.00
1996-97 2186 20 1664.5 1,705.00
1997-98 2623 20 2214.8 1,827.00
1998-99 3148 20 2870.4 1,918.00
1999-00 3777 20 3100 2,025.00
2000-01 4533 20 3720 2,265.00
2001-02 5439 20 4501 2,435.00
2002-03 6529 20 5401 2,617.00
2003-04 7729 20 6481 2,813.00
2004-05 9034 20 3,024.00
*These figures do not include production from unorganized sector, which is estimate
expenditure on R&D
1983-84 401985-86 48 All Figures in Rs Crore
1986-87 50 Domestic Market Exports Imports
1990-91 60 2003 30365 12826 2865
1991-92 80 2004 32575 15213 2956
1992-93 95 2005 34128 17857 3139
1993-94 125 2006 39989 22216 4515
1994-95 140 2007 45367 24942 5867
1995-96 160 2008 50946 30760 6734
1996-97 185 2009 55454 38433 8552
1997-98 2201998-99 260
1999-00 320
2000-01 370.00
2001-02 435.00
2002-03 672.00
2003-04* 1,054.00
2004-05* 1,686.00
Imports
-
8/8/2019 aarti iapm
10/60
-
8/8/2019 aarti iapm
11/60
Formulations(Growth(%) total volume domestic Investment i
1945 6.5 2361
2140 10 2598 Year
2350 9.8 2830 1965
3150 12.5 3700 1973
3420 8.6 4060 1977
3840 12.3 4570 1979
4800 25 5700 1982
6000 25 7150 1985
6900 15 8220 1988
7935 15 9453 1993
9125 15 10947 1994
10494 15 12680 1995
12068 15 14691 1996
13878 15 17026 1997
15960 15 19737 1998
18354 15 22887 1999
21104 15 26543 2000
24185 15 30714 2001
27692 15 35421 2002
31946 15 40980 2003
d at an additional 35% of the production. 2004
otal Market Size
42326
47332
52029
62566
68442
78610
89335
-
8/8/2019 aarti iapm
12/60
-
8/8/2019 aarti iapm
13/60
n Pharmaceutical Industry
(Rs. In crores)
Amount al Increase (%)
140 60.71
225 100
450 11.11
500 20
600 8.33
650 23.08
800 32.5
1,060 13.21
1,200 8.33
1,300 23.08
1,600 15
1,840 16.85
2,150 16.27
2,500 16
2,900 16
3,364 16
3,903 16
4,528 16
5,253 16
-
8/8/2019 aarti iapm
14/60
-
8/8/2019 aarti iapm
15/60
Company 1 Year 9 Month 6 Month 3 Month 1 Month
Aarey Drugs 44 46.35 34.65 23.25 26.3
-42.27% -45.20% -26.70% 9.25% -3.42%
Aarti Drugs 69.15 87 93.15 119.85 134.35
106.29% 63.97% 53.14% 19.02% 6.18%
Abbott India 561.3 789.85 890.05 1029.25 1128.3
101.57% 43.24% 27.12% 9.92% 0.27%
ABL Biotech 22.8 18.3 20.8 17.3 22.35
-17.32% 3.01% -9.37% 8.96% -15.66%
Advik Labors 4.02 3.88 4 4.15 5.47
46.02% 51.29% 46.75% 41.45% 7.31%
Ahlcon Parent 37.9 37.9 49.85 64.75 80.05138.13% 138.13% 81.04% 39.38% 12.74%
Ajanta Pharma 88.95 97.4 151.65 188.95 219.85
166.61% 143.48% 56.38% 25.51% 7.87%
Albert David 84.35 121.35 116.35 125.3 126.05
53.94% 7.00% 11.60% 3.63% 3.01%
Alembic 47.25 45.1 45.75 45.9 56.85
26.14% 32.15% 30.27% 29.85% 4.84%
Alpa Laboratori 13.54 11.84 12.82 15.24 17.45
21.49% 38.94% 28.32% 7.94% -5.73%
Ambalal Sarabha 12.35 12.51 11.11 10.14 11.38
-13.12% -14.23% -3.42% 5.82% -5.71%
Amrutanjan Heal 378.15 435 575.6 791.9 741.45
82.73% 58.85% 20.05% -12.74% -6.80%
Ankur Drugs 155.15 200.3 195.1 176.25 172
-12.02% -31.85% -30.04% -22.55% -20.64%
Anuh Pharma 352.65 313.3 410.5 369.85 544.85
60.12% 80.23% 37.55% 52.67% 3.63%
Anus Labs 12.06 7.98 6.92 6.02 5.45
-55.89% -33.33% -23.12% -11.63% -2.39%
-
8/8/2019 aarti iapm
16/60
Arvind Remedies 1.83 1.82 1.89 1.83 1.86
12.57% 13.19% 8.99% 12.57% 10.75%
Astec Life 83.9 89.45 46.5 62.1 74.35
-7.15% -12.91% 67.53% 25.44% 4.77%
AstraZeneca 805.25 945.6 872.05 822 1224.8
49.12% 26.98% 37.69% 46.08% -1.96%
Auro Labs 2.87 4.14 3.3 4.51 3.8
78.40% 23.67% 55.15% 13.53% 34.74%
Aurobindo Pharm 704.45 863.25 922.15 834.15 980.6
48.61% 21.27% 13.53% 25.51% 6.76%
Aventis Pharma 1449.65 1548.2 1626.9 1850 1868.75
24.54% 16.61% 10.97% -2.41% -3.39%
Bafna Pharma 23.1 34.15 29 41.85 42.25
85.50% 25.48% 47.76% 2.39% 1.42%
Bal Pharma 24.35 27.1 25.75 26.25 29.6
21.15% 8.86% 14.56% 12.38% -0.34%
BDH Industries 12.87 15.15 14.51 22.95 28.25
73.27% 47.19% 53.69% -2.83% -21.06%
Beryl Drugs 11.18 6.61 10.29 18.25 31.95204.56% 415.13% 230.90% 86.58% 6.57%
Bharat Immuno 18.65 20.25 19.05 17.85 21.4
21.98% 12.35% 19.42% 27.45% 6.31%
Biocon 230.65 267.3 269.05 287.8 312.9
48.78% 28.38% 27.54% 19.23% 9.67%
Biofil Chem 2.43 4.39 3.77 3.5 3.8
55.14% -14.12% - 7.71% -0.79%
Brawn Pharma 14.63 15.15 15.15 11.5 11.4
12.78% 8.91% 8.91% 43.48% 44.74%
Cadila Health 299.91 420.92 528.96 598.1 629.1
108.16% 48.32% 18.02% 4.38% -0.76%
Caplin Point La 7.35 8.39 8.46 12.41 17.05
89.12% 65.67% 64.30% 12.01% -18.48%
-
8/8/2019 aarti iapm
17/60
Celestial Labs 21.45 27 34.45 32.55 37
50.82% 19.81% -6.10% -0.61% -12.57%
Cipla 270.45 331.1 315.2 324.35 325.8
12.87% -7.81% -3.16% -5.89% -6.31%
Colinz Labs 4.8 4.31 4.93 5.73 7.253.75% 71.23% 49.70% 28.80% 2.50%
Coral Labs 47 61.45 59 78.15 134.05
137.02% 81.29% 88.81% 42.55% -16.90%
Country Condos 7.87 6.55 4.94 3.56 3.96
-50.95% -41.07% -21.86% 8.43% -2.53%
DIL 208.8 255.05 247 262.6 325.35
114.22% 75.38% 81.09% 70.34% 37.48%
Dishman Pharma 215.65 231.65 204.85 193.1 215.9
-10.36% -16.56% -5.64% 0.10% -10.47%
Divis Labs 513.5 635.7 632.5 749.3 756.7
45.07% 17.19% 17.78% -0.58% -1.55%
Dr Reddys Labs 779.85 1123.2 1135.6 1404.75 1351.25
76.74% 22.71% 21.37% -1.88% 2.00%
Elder Healthcar 37.6 62.15 74.4 83.05 91.1
169.95% 63.31% 36.42% 22.22% 11.42%
Elder Pharma 295.75 263.7 368.95 350.3 367.2
37.55% 54.27% 10.26% 16.13% 10.78%
FDC 46 64.25 75.6 95.8 86
135.65% 68.72% 43.39% 13.15% 26.05%
Fresenius Kabi 81.5 93.35 115.95 127.55 154.3
77.42% 54.90% 24.71% 13.37% -6.29%
Fulford 575.9 733.45 890.15 981.35 1091.8
78.23% 39.95% 15.31% 4.60% -5.99%
Gennex Labs 15.5 22.05 1.9 1.48 1.63
-90.39% -93.24% -21.58% 0.68% -8.59%
GlaxoSmithKline 1441.3 1663.5 1702.05 2105.85 2014.4
-
8/8/2019 aarti iapm
18/60
32.50% 14.80% 12.20% -9.31% -5.20%
Glenmark 219.45 251.05 255.95 266.05 270.25
31.94% 15.34% 13.13% 8.83% 7.14%
Godavari Drugs 5.48 6.3 5.2 7 7.99
36.13% 18.41% 43.46% 6.57% -6.63%
Granules India 79.05 90.75 94.85 96.1 90.75
18.34% 3.09% -1.37% -2.65% 3.09%
Gufic Bio 6.29 6.26 6.7 5.89 6.6
10.97% 11.50% 4.18% 18.51% 5.76%
Guj Terce Labs 5.88 18.3 15.55 10.45 14.75
122.79% -28.42% -15.76% 25.36% -11.19%
Guj Themis 6.12 8.5 10.28 12.55 10.283.66% 32.24% 9.34% -10.44% 10.20%
Hester Bio 86.45 98.5 117.25 129.25 143.5
79.29% 57.36% 32.20% 19.92% 8.01%
Hikal 340.6 410.1 362.35 357.75 388.55
26.91% 5.40% 19.29% 20.82% 11.25%
Hiran Orgochem 47.65 8.99 8.9 9.62 10.1
-78.97% 11.46% 12.58% 4.16% -0.79%
Ind-Swift 25.55 29.45 28.55 30.55 33.9
69.28% 46.86% 51.49% 41.57% 27.58%
Ind-Swift Labs 57.6 68.6 64.2 69.1 81.35
120.23% 84.91% 97.59% 83.57% 55.93%
Indoco Remedies 202.55 289.05 319.4 408.05 414.05
110.02% 47.17% 33.19% 4.25% 2.74%
Inwinex Pharma 3.09 5.38 43.8 31.5 28.15
754.37% 390.71% -39.73% -16.19% -6.22%
Ipca Labs 138 201.37 217.64 271.35 278.3
106.56% 41.56% 30.97% 5.05% 2.43%
Ishita Drugs 10.63 9.12 9.26 14.3 13.47
98.49% 131.36% 127.86% 47.55% 56.64%
-
8/8/2019 aarti iapm
19/60
Jagson Pharma 18.6 17.4 17.6 20.3 21.1
41.94% 51.72% 50.00% 30.05% 25.12%
JB Chemicals 48.9 50.7 67.1 78.3 98.8
118.00% 110.26% 58.87% 36.14% 7.89%
Jenburkt Pharma 32.9 37.5 49.95 71.35 79.25
135.71% 106.80% 55.26% 8.69% -2.15%
Jupiter Bio 76.95 79.7 80.95 82.65 89.4
39.51% 34.69% 32.61% 29.89% 20.08%
Kappac Pharma 7.5 7.87 22.8 42.15 48.65
670.67% 634.43% 153.51% 37.13% 18.81%
KDL Biotech 8.94 9.25 12.35 11.65 12.85
44.52% 39.68% 4.62% 10.90% 0.54%
Kerala Ayur 52.25 47.25 49.5 43.15 49.7
-1.53% 8.89% 3.94% 19.24% 3.52%
Kilitch Drugs 83.5 79.15 97.4 92.9 113.8
51.68% 60.01% 30.03% 36.33% 11.29%
Kopran 16.65 25.2 30.45 32.8 42
140.24% 58.73% 31.36% 21.95% -4.76%
Krebs Biochem 29.65 31 34.05 34.25 37.239.29% 33.23% 21.29% 20.58% 11.02%
Lactose India 6.7 8.6 11.5 22.15 16.9
152.24% 96.51% 46.96% -23.70%-
Lincoln Pharma 33.65 27.9 30.5 30.75 35.3
21.84% 46.95% 34.43% 33.33% 16.15%
Lupin 193.41 275.81 300.77 368.84 380.57
86.42% 30.72% 19.88% -2.25% -5.26%
Lyka Labs 24.75 31.7 28.4 28 29.1
21.82% -4.89% 6.16% 7.68% 3.61%
Makers Labs 17.95 17.4 35.05 47.8 49.4
140.95% 148.56% 23.40% -9.52% -12.45%
Mangalam Drugs 10.92 11.35 13.45 13.78 16.15
40.75% 35.42% 14.28% 11.54% -4.83%
-
8/8/2019 aarti iapm
20/60
Marksans Pharma 6.13 4.94 5.03 4.19 4.17
-36.70% -21.46% -22.86% -7.40% -6.95%
Medicamen Bio 17.3 21.5 34 27 30
70.23% 36.98% -13.38% 9.07% -1.83%
Merck 401.8 561.25 618 630.1 715.9573.98% 24.55% 13.11% 10.94% -2.36%
Morepen Lab 8.29 8.93 7.97 7.53 7.13
-21.23% -26.88% -18.07% -13.28% -8.42%
Natco Pharma 101.9 111.95 123.55 168.8 194.1
158.78% 135.55% 113.44% 56.22% 35.86%
Natural Capsule 29.85 47.2 39.75 42 46.8
42.71% -9.75% 7.17% 1.43% -8.97%
Nectar Life 21.4 28.6 36.75 37.1 34.7
52.80% 14.34% -11.02% -11.86% -5.76%
Neuland Lab 135.9 116.9 99.25 88.25 96.2
-29.51% -18.05% -3.48% 8.56% -0.42%
NGL Fine Chem 13.5 16.1 19.05 16.35 23
55.93% 30.75% 10.50% 28.75% -8.48%
Novartis India 490.35 556 523.85 594.35 644.85
33.82% 18.02% 25.26% 10.41% 1.76%
Nutraplus Prod 9 8.43 17.45 16.85 16.11
105.56% 119.45% 6.02% 9.79% 14.84%
Orchid Chemical 119.2 199.9 165.9 143.25 188.9
56.71% -6.55% 12.60% 30.40% -1.11%
Ortin Labs 13.4 19 13.01 17 27.6
105.22% 44.74% 111.38% 61.76% -0.36%
Panacea Biotec 182.85 186.1 184.35 174.6 184.55
3.91% 2.10% 3.06% 8.82% 2.95%
Panchsheel Org 13.59 33.5 37 18.5 20.45
69.98% -31.04% -37.57% 24.86% 12.96%
Parabolic Drugs 64.8 64.8 64.8 64.8 54.3
-
8/8/2019 aarti iapm
21/60
-11.57% -11.57% -11.57% -11.57% 5.52%
Parenteral Drug 99.1 121.55 200.75 193.3 254.9
184.16% 131.67% 40.27% 45.68% 10.47%
Pfizer 815.45 962.35 930.1 1039.25 1164.45
33.20% 12.87% 16.78% 4.52% -6.72%
Pharmaids Pharm 3.15 3.5 3.9 4.14 4.08
37.14% 23.43% 10.77% 4.35% 5.88%
Piramal Health 325.15 414.5 419.5 514.9 485.5
55.56% 22.03% 20.57% -1.77% 4.18%
Piramal Life 79 79.65 81.7 131.95 151.7
87.47% 85.94% 81.27% 12.24% -2.37%
Plethico Pharma 283.4 342 396.15 391.3 391.840.33% 16.29% 0.39% 1.64% 1.51%
Poonam Pharma 1.7 1.54 1.62 1.86 3.47
105.29% 126.62% 115.43% 87.63% 0.58%
Protochem 1.55 1.44 1.29 1.2 1.07
-23.23% -17.36% -7.75% -0.83% 11.21%
Ranbaxy Labs 322.9 483.65 479.35 429.85 452.55
56.04% 4.18% 5.11% 17.22% 11.34%
Roopa Industrie 4.12 5.5 6.88 8.19 9.61
227.43% 145.27% 96.08% 64.71% 40.37%
RPG Life 43.8 63.95 73 70.05 97.4
128.20% 56.29% 36.92% 42.68% 2.62%
Rubra Medicamen 29.99 21.5 17.95 70.3 29.2
-35.31% -9.77% 8.08% -72.40% -33.56%
Saamya Biotech 7.03 6.25 8.96 8.7 10.09
27.88% 43.84% 0.33% 3.33% -10.90%
Samrat Pharma 9.49 10.52 13.93 16 17.35
106.01% 85.84% 40.34% 22.19% 12.68%
Sandu Pharma 10.7 14.04 13.89 14.2 15.95
40.00% 6.70% 7.85% 5.49% -6.08%
-
8/8/2019 aarti iapm
22/60
Sanjivani Paren 20.85 26.4 53.45 42.95 46.05
120.38% 74.05% -14.03% 6.98% -0.22%
Sequent Scienti 64.25 107.6 136.5 149.95 142.2
95.64% 16.82% -7.91% -16.17% -11.60%
Sharon Bio Medi 75.6 79.5 108.75 129.15 158.5
101.06% 91.19% 39.77% 17.69% -4.10%
Shasun Chemical 29.45 37.8 37.75 62.65 78.15
173.17% 112.83% 113.11% 28.41% 2.94%
Shilpa 154 197.4 243.65 299.7 338.95
120.36% 71.91% 39.28% 13.23% 0.12%
Smruthi Organic 60.95 79.05 94.9 101.1 141.25
156.85% 98.04% 64.96% 54.85% 10.83%
SMS Pharma 142.15 139.75 160.3 165.05 187.1
40.34% 42.75% 24.45% 20.87% 6.63%
Solvay Pharma 770.75 1411.4 2851.45 2430.45 2696.65
249.02% 90.60% -5.66% 10.68% -0.24%
SS Organics 3.83 6.28 5.7 4.05 3.55
89.30% 15.45% 27.19% 79.01% 104.23%
Sterling Bio 114.5 93.7 101.8 110.3 107.25-6.68% 14.03% 4.96% -3.13% -0.37%
Stride Arcolab 162.5 214.35 310 353.95 445.5
163.88% 100.05% 38.32% 21.15% -3.75%
Sun Pharma 1190 1495.35 1549 1680.6 1772.55
45.84% 16.06% 12.04% 3.27% -2.09%
Sun Pharma Adv 69.3 84.55 86.5 89.3 99.15
35.86% 11.35% 8.84% 5.43% -5.04%
Surya Pharma 106.25 119.15 163.1 168.1 185.95
168.75% 139.66% 75.08% 69.87% 53.56%
Suven Life Scie 29.6 28.45 26.25 27.5 27.8
-4.90% -1.05% 7.24% 2.36% 1.26%
Syncom Formula 21.45 20.95 27.5 34.35 35.05
67.60% 71.60% 30.73% 4.66% 2.57%
-
8/8/2019 aarti iapm
23/60
Syncom Health 87.85 87.85 99.55 38.85 41.25
-56.00% -56.00% -61.18% -0.51% -6.30%
Themis Medicare 141.15 156.45 184.05 237.3 248.2
68.72% 52.22% 29.39% 0.36% -4.05%
Tonira Pharma 24.5 32.05 28.1 29.95 29.518.57% -9.36% 3.38% -3.01% -1.53%
Torrent Cables 119.1 131.55 115.5 112.4 122.25
2.81% -6.92% 6.02% 8.94% 0.16%
Torrent Pharma 264.4 397.55 450.05 564.55 556
103.37% 35.25% 19.48% -4.76% -3.29%
Transchem 15.1 16.6 11.87 16.85 13.5
-2.72% -11.51% 23.76% -12.82% 8.81%
Trimurthi Drugs 33.55 5.55 4.73 4.25 4.44
-87.66% -25.41% -12.47% -2.59% -6.76%
TTK Healthcare 179 241.05 279.5 340.05 391.3
125.25% 67.27% 44.26% 18.57% 3.04%
Twilight Litaka 49.15 51.3 80.55 104.9 172.25
258.49% 243.47% 118.75% 67.97% 2.29%
Unichem Labs 226.45 274.1 358.3 422.95 435.1
94.86% 60.98% 23.15% 4.33% 1.41%
Unjha Formula 4.9 4.54 4.37 4.61 5.47
-2.86% 4.85% 8.92% 3.25% -12.98%
Vardhman Lab 4 3.81 2.94 4.07 4.99
53.75% 61.42% 109.18% 51.11% 23.25%
Venkat Pharma 4.57 6.1 5.1 4.61 4.98
2.19% -23.44% -8.43% 1.30% -6.22%
Venmax Drugs 6.15 6.15 6.15 6.15 8.26
23.25% 23.25% 23.25% 23.25% -8.23%
Venus Remedies 281.5 211.55 232.15 261.35 268.85
6.87% 42.21% 29.59% 15.11% 11.90%
Vikram Thermo 19.15 17 17.35 20.1 26.15
-
8/8/2019 aarti iapm
24/60
27.15% 43.24% 40.35% 21.14% -6.88%
Vista Pharma 6.69 6.9 7.45 7.08 16.43
169.81% 161.59% 142.28% 154.94% 9.86%
Vivimed Labs 93.95 135.55 128 170.25 201.5
161.89% 81.52% 92.23% 44.52% 22.11%
Wanbury 75.8 70 71.75 78.8 81.9
7.65% 16.57% 13.73% 3.55% -0.37%
Welcure Drugs 2.9 2.7 2.77 2.96 3.11
8.62% 16.67% 13.72% 6.42% 1.29%
Wintac 24 22.85 32.15 34.2 31.25
19.79% 25.82% -10.58% -15.94% -8.00%
Wockhardt 157.45 177.05 141.9 131.3 144.5543.00% 27.17% 58.67% 71.48% 55.76%
Wyeth 626.05 734.6 744.05 779.9 839.5
27.59% 8.73% 7.35% 2.42% -4.85%
Zandu Realty 6968.5 9918.1 4152.45 3033.25 3101.1
-55.50% -68.74% -25.33% 2.23% -0.01%
Zenith Health 0.73 0.73 1.23 1.27 1.21
83.56% 83.56% 8.94% 5.51% 10.74%
Zenotech Labs 105.9 115.45 115.05 113.5 93.05
-19.12% -25.81% -25.55% -24.54% -7.95%
Zyden Gentec 3.2 2.68 2.15 2.39 1.83
-28.13% -14.18% 6.98% -3.77% 25.68%
-
8/8/2019 aarti iapm
25/60
2 Week 1 Week Last Price
25.05 24.65 25.4
1.40% 3.04%
138 137.7 142.65
3.37% 3.59%
1155.75 1168.9 1,131.40
-2.11% -3.21%
20.95 18.7 18.85
-10.02% 0.80%
5.95 5.35 5.87
-1.34% 9.72%
88 96.4 90.252.56% -6.38%
203.95 226.15 237.15
16.28% 4.86%
129.85 133.75 129.85
- -2.92%
57.35 61.1 59.6
3.92% -2.45%
17.35 17 16.45
-5.19% -3.24%
11.6 11.04 10.73
-7.50% -2.81%
727.4 708.1 691
-5.00% -2.41%
123.35 137.4 136.5
10.66% -0.66%
555.65 574.85 564.65
1.62% -1.77%
5.18 5.47 5.32
2.70% -2.74%
-
8/8/2019 aarti iapm
26/60
2.03 2.07 2.06
1.48% -0.48%
72.85 73.95 77.9
6.93% 5.34%
1210.3 1231 1,200.75
-0.79% -2.46%
4.21 4.74 5.12
21.62% 8.02%
1007 1033.8 1,046.90
3.96% 1.27%
1834 1810.4 1,805.35
-1.56% -0.28%
45.1 44.35 42.85
-4.99% -3.38%
28.75 29.6 29.5
2.61% -0.34%
24.55 24.85 22.3
-9.16% -10.26%
33.45 34.3 34.051.79% -0.73%
24.85 22.9 22.75
-8.45% -0.66%
340.45 336.2 343.15
0.79% 2.07%
3.84 3.88 3.77
-1.82% -2.84%
14.18 14.6 16.5
16.36% 13.01%
625.95 622.65 624.3
-0.26% 0.26%
14.55 13.75 13.9
-4.47% 1.09%
-
8/8/2019 aarti iapm
27/60
33.7 32.4 32.35
-4.01% -0.15%
304.3 307.15 305.25
0.31% -0.62%
6.75 7.39 7.389.33% -0.14%
107.35 104.7 111.4
3.77% 6.40%
4.35 3.84 3.86
-11.26% 0.52%
437.35 421.7 447.3
2.28% 6.07%
203.2 197.5 193.3
-4.87% -2.13%
738.3 754.65 744.95
0.90% -1.29%
1338.95 1339.9 1,378.30
2.94% 2.87%
106.25 143.9 101.5
-4.47% -29.46%
402.85 406.75 406.8
0.98% 0.01%
82.85 94.45 108.4
30.84% 14.77%
148.5 151.1 144.6
-2.63% -4.30%
1045.65 1003.35 1,026.45
-1.84% 2.30%
1.62 1.54 1.49
-8.02% -3.25%
1944.4 1871.9 1,909.70
-
8/8/2019 aarti iapm
28/60
-1.78% 2.02%
268.2 284.9 289.55
7.96% 1.63%
8.07 7.5 7.46
-7.56% -0.53%
92.25 92 93.55
1.41% 1.68%
7.13 6.8 6.98
-2.10% 2.65%
14.2 14 13.1
-7.75% -6.43%
10.93 10.9 11.242.84% 3.12%
146.5 152.5 155
5.80% 1.64%
388.25 438.45 432.25
11.33% -1.41%
10.01 10 10.02
0.10% 0.20%
35.6 42.2 43.25
21.49% 2.49%
82 123.7 126.85
54.70% 2.55%
400.85 417.1 425.4
6.12% 1.99%
30.1 27 26.4
-12.29% -2.22%
274.45 287 285.05
3.86% -0.68%
19.52 21.61 21.1
8.09% -2.36%
-
8/8/2019 aarti iapm
29/60
23.9 26 26.4
10.46% 1.54%
101.35 107.85 106.6
5.18% -1.16%
76.1 79.1 77.55
1.91% -1.96%
102.35 105.15 107.35
4.89% 2.09%
68 58.75 57.8
-15.00% -1.62%
13.5 13.37 12.92
-4.30% -3.37%
52.35 52 51.45
-1.72% -1.06%
113.4 107.9 126.65
11.68% 17.38%
39.85 41.05 40
0.38% -2.56%
36.5 36.5 41.313.15% 13.15%
18.25 17.75 16.9
-7.40% -4.79%
36.75 40.35 41
11.56% 1.61%
360.55 373.6 360.55
- -3.49%
28.15 30.5 30.15
7.10% -1.15%
46.15 44.7 43.25
-6.28% -3.24%
16 15.9 15.37
-3.94% -3.33%
-
8/8/2019 aarti iapm
30/60
4 3.98 3.88
-3.00% -2.51%
30.4 30.95 29.45
-3.12% -4.85%
697.65 706.4 699.050.20% -1.04%
7.07 6.74 6.53
-7.64% -3.12%
189.6 233.95 263.7
39.08% 12.72%
43 43.75 42.6
-0.93% -2.63%
31.75 33.4 32.7
2.99% -2.10%
96 95.75 95.8
-0.21% 0.05%
22.35 22.35 21.05
-5.82% -5.82%
648.6 663.1 656.2
1.17% -1.04%
19.04 19.2 18.5
-2.84% -3.65%
195.9 192.35 186.8
-4.65% -2.89%
28 27.9 27.5
-1.79% -1.43%
184.15 188 190
3.18% 1.06%
19.95 21.8 23.1
15.79% 5.96%
57.95 55.1 57.3
-
8/8/2019 aarti iapm
31/60
-1.12% 3.99%
255.65 251.75 281.6
10.15% 11.86%
1152.65 1132.9 1,086.20
-5.76% -4.12%
4.28 3.75 4.32
0.93% 15.20%
500.55 496.8 505.8
1.05% 1.81%
160.25 152.15 148.1
-7.58% -2.66%
397.75 400.4 397.7-0.01% -0.67%
4.49 3.67 3.49
-22.27% -4.90%
1.05 1.06 1.19
13.33% 12.26%
473.3 480.9 503.85
6.45% 4.77%
10.33 13.9 13.49
30.59% -2.95%
99.75 104.3 99.95
0.20% -4.17%
24.95 21.15 19.4
-22.24% -8.27%
9.42 9.36 8.99
-4.56% -3.95%
19.1 19.4 19.55
2.36% 0.77%
14.95 15.2 14.98
0.20% -1.45%
-
8/8/2019 aarti iapm
32/60
42.1 47 45.95
9.14% -2.23%
123.1 130.45 125.7
2.11% -3.64%
166.95 145.65 152
-8.95% 4.36%
82.05 78.45 80.45
-1.95% 2.55%
352.65 337.6 339.35
-3.77% 0.52%
170.4 149.75 156.55
-8.13% 4.54%
192.05 200.35 199.5
3.88% -0.42%
2657.2 2687 2,690.10
1.24% 0.12%
5.17 6.85 7.25
40.23% 5.84%
105.7 106.4 106.851.09% 0.42%
430.1 425 428.8
-0.30% 0.89%
1766 1776.4 1,735.50
-1.73% -2.30%
94.75 95.8 94.15
-0.63% -1.72%
203 287.15 285.55
40.67% -0.56%
28.95 29.65 28.15
-2.76% -5.06%
36.2 36 35.95
-0.69% -0.14%
-
8/8/2019 aarti iapm
33/60
40.85 39.65 38.65
-5.39% -2.52%
242.4 247.2 238.15
-1.75% -3.66%
29 28.4 29.050.17% 2.29%
117.9 116.25 122.45
3.86% 5.33%
558.1 545.7 537.7
-3.66% -1.47%
14.93 14.1 14.69
-1.61% 4.18%
4.54 4.6 4.14
-8.81% -10.00%
375.5 400 403.2
7.38% 0.80%
178.35 171.05 176.2
-1.21% 3.01%
419.4 422.8 441.25
5.21% 4.36%
5.2 5.05 4.76
-8.46% -5.74%
5.58 5.6 6.15
10.22% 9.82%
4.94 4.72 4.67
-5.47% -1.06%
8.4 7.97 7.58
-9.76% -4.89%
268.2 280.75 300.85
12.17% 7.16%
23 23.55 24.35
-
8/8/2019 aarti iapm
34/60
5.87% 3.40%
15.78 19.32 18.05
14.39% -6.57%
208.9 237.85 246.05
17.78% 3.45%
77.7 81.55 81.6
5.02% 0.06%
3.31 3.28 3.15
-4.83% -3.96%
29.5 32.85 28.75
-2.54% -12.48%
186.65 226.65 225.1520.63% -0.66%
806.85 806.8 798.75
-1.00% -1.00%
3125.75 3037.3 3,100.75
-0.80% 2.09%
1.24 1.26 1.34
8.06% 6.35%
92.4 93.35 85.65
-7.31% -8.25%
2.41 2.42 2.3
-4.56% -4.96%
-
8/8/2019 aarti iapm
35/60
-
8/8/2019 aarti iapm
36/60
-
8/8/2019 aarti iapm
37/60
2006 2007
Gross Sales 271 307.09
Net Sales 244.8 276.3
Other Income 8.81 6.74
Value Of Output 252.06 270.01
Cost of Production 215.58 244.1
Selling Cost 8.17 9.87PBIDT 33.65 35.87
PBDT 23.03 24.64
PBIT 25.73 27.25
PBT 15.11 16.02
PAT 12.73 12.77
CP 20.65 21.39
Revenue earnings in forex 78.63 93.13
Revenue expenses in forex 73.33 91.09
Capital earnings in forex 0 0
Capital expenses in forex 0.42 0.72Book Value (Unit Curr) 74.53 84.07
Market Capitalisation 103.69 72.6
CEPS 17.43 18.1
(annualised) (Unit Curr)
EPS (annualised) (Unit Curr) 10.67 10.73
Dividend (annualised%) 15 12
Payout (%) 14.09 11.14
Cash Flow From Operating Activities 15.31 27.11
Cash Flow From Investing Activities -46.17 -24.17
Cash Flow From Financing Activities 28.3 -4.76
Rate of Growth (%)
ROG-Net Worth (%) 13.99 12.8
ROG-Capital Employed (%) 23.65 8.03
ROG-Gross Block (%) 33.4 5.95
ROG-Gross Sales (%) 5.52 13.32
ROG-Net Sales (%) 5.04 12.87
ROG-Cost of Production (%) 11.27 5.33
ROG-Total Assets (%) 20.45 0.9
ROG-PBIDT (%) -3.42 6.6
ROG-PBDT (%) -17.04 6.99
ROG-PBIT (%) -7.08 5.91
ROG-PBT (%) -26.69 6.02
ROG-PAT (%) -9.46 0.31
ROG-CP (%) -2.64 3.58
ROG-Revenue earnings in forex (%) 11.41 18.44
ROG-Revenue expenses in forex (%) 41.54 24.22
ROG-Market Capitalisation (%) -35.39 -29.98
-
8/8/2019 aarti iapm
38/60
RS IN CR
2008 2009 2010
335.85 409.69 496.95
310.73 376.51 471.42
1.84 0.17 0.45
319.97 369.56 467.66
273.86 304.87 388.46
8.96 10.75 13.540.89 58.98 74.04
27.46 34.19 57.34
31.26 47.94 60.52
17.83 23.15 43.82
13.07 15.05 26.1
22.7 26.09 39.62
109.3 139.36 152.79
84 96.82 116.22
0 0 0
0.06 1.34 0.6393.13 102.46 120.15
61.42 44.5 123.7
19.08 21.77 32.98
10.85 12.34 21.43
18 30 50
16.6 24.29 24.1
30.95 60.86 43.47
-31.78 -6.45 -23.37
-0.68 -54.34 -19.15
10.77 10.22 17.39
7.98 -4.95 6.72
9.9 14.41 7.57
9.37 21.99 21.3
12.46 21.17 25.21
16.83 10.72 26.29
14.79 -2.14 5.72
13.99 44.24 25.53
11.44 24.51 67.71
14.72 53.36 26.24
11.3 29.84 89.29
2.35 15.15 73.42
6.12 14.93 51.86
17.36 27.5 9.64
-7.78 15.26 20.04
-15.4 -27.55 177.98
-
8/8/2019 aarti iapm
39/60
Particulars 31-Mar-06 31-Mar-07 31-Mar-08 31-Mar-09
Equity Capital 11.71 11.71 11.71 11.71
Reserves & sirplus 75.57 86.73 97.34 108.27
Less: misc exps 2.27 1.15 3.72 0.00
Net Worth 85.01 97.29 105.33 119.98
Borrowings
Long term 30.94 42.64 47.95 72.04Short-Term-Bank 67.01 74.93 70.71 80.71
Short-Term-Others 84.13 74.99 86.51 25.73
Total Borrowings 182.09 192.56 205.17 178.48
TOTAL LIABILITIES 267.10 289.85 310.50 298.46
Gross Block 200.60 212.53 233.59 267.26
Less ; dep 50.95 62.36 74.47 87.88
Net Block 149.65 150.17 159.12 179.38
Capital WIP 0.16 13.91 14.86 0.8Investments 20.40 21.35 33.53 21.38
Inventories 62.55 57.23 61.55 57.20
Sundry Debtors 69.73 73.72 97.01 106.33
Cash and Bank Balance 1.61 2.92 1.95 2.10
Total Current Assets 133.89 133.87 160.51 165.63
Loans and Advances 32.58 37.07 26.30 18.75
4.51 1.37 0.87 0.76
Current assets , L & A 170.98 172.31 187.68 185.14
rrent liabilities & provisi 74.09 67.89 84.69 88.23
NWC 96.89 104.42 102.99 96.91
TOTAL ASSETS 267.10 289.85 310.50 298.46
SALES 271 307.09 335.85 409.69
COGS 237.35 271.22 294.96 350.71
RATIOS
CURRENT RATIO 2.31 2.54 2.22 2.10
INVENTORY TURNOVER 4.33 5.37 5.46 7.16
DEBTORS TURNOVER 3.89 4.17 3.46 3.85
PAYABLES TURN OVER 3.20 3.99 3.48 3.97
Fixed Deposits
-
8/8/2019 aarti iapm
40/60
31-Mar-10
12.11
134.34
5.36
141.09
64.0875.54
38.02
177.64
318.73
287.48
103.95
183.53
3.4021.38
58.58
118.45
2.99
180.02
19.52
0.78
200.32
89.9
110.42
318.73
496.95
422.91
2.23 QUITE STABLE
8.48
4.20
4.70
INCREASING SOCOMPANY ISMANAGING IT WELL
INCREASING SLIGHTLYAND STABLE
REPAYING LIABILITIESFREQUENTLY
-
8/8/2019 aarti iapm
41/60
FINANCIAL MODEL FOR AARTI DRUGS
ROFIT & LOSS STATEMENT
Particulars 31-Mar-01 31-Mar-02 31-Mar-03 31-Mar-04
Sales 149.92 174.61 192.14 237.70COGS 129.23 149.29 167.73 211.07
Profitbef int & dep 20.68 25.32 24.42 26.64
Interest 8.31 8.66 5.50 3.86
Depreciation 3.89 4.38 5.10 5.72
pbt 8.48 12.29 13.82 17.06
tax rate 0.07 0.11 0.17 0.29
pat 7.91 10.93 11.44 12.08
Equity Capital 13.01 13.01 11.71 11.71
Dividend % 0.15 0.10 0.15 0.30
Payout(eq. cap*div %) 1.95 1.30 1.76 3.51
BALANCE SHEET
Particulars 31-Mar-01 31-Mar-02 31-Mar-03 31-Mar-04
Equity Capital 13.01 13.01 11.71 11.71
Reserves & sirplus 34.11 44.20 46.76 54.78
Less: misc exps 0.23 0.16 0.09 4.52
Net Worth 46.89 57.05 58.38 61.96Borrowings
Long term 28.41 22.77 26.63 30.81
Short-Term-Bank 31.79 39.38 44.64 53.69
Short-Term-Others 4.00 6.93 12.28 22.31
Total Borrowings 64.19 69.08 83.55 106.81
TOTAL LIABILITIES 111.08 126.13 141.93 168.78
Gross Block 78.58 92.77 102.04 117.87
Less : depriciation 21.07 25.42 30.09 35.81
Net Block 57.51 67.34 71.95 82.06
Capital WIP 3.03 0.00 0.00 6.18
Investments 1.17 1.29 1.33 0.31
Current assets , L & A 80.45 87.43 106.99 149.26
rrent liabilities & provisi 31.07 29.92 34.48 61.53
NWC 49.38 57.50 72.50 87.73
-
8/8/2019 aarti iapm
42/60
TOTAL ASSETS 111.08 126.13 145.77 176.28
ROUGH SHEET
4 5 6 7
Term 3,081.23 4,680.16 3,094.12 4,263.63
Short-Term-Bank 5,368.61 4,524.31 6,701.47 7,493.42
Short-Term-Others 2,231.35 4,923.25 8,413.26 7,499.31
Total Borrowings 10,681.19 14,127.72 18,208.85
Gross Block 11,787.22 15,037.17 20,059.68
Less : Depreciation 3,581.36 4,262.30
Net Block 8,205.86 10,774.87 14,964.52
Captal Work In Progress 617.92
Investments 31.44 145.7 2,040.49 2,134.85
Current Assets, Loans and AdvancesCurrent Liabilities 6,152.53 5,866.42 6,298.15
Net Working Capital 8,773.09 9,265.37
Book Value 52.92 62.5 72.6
Earning per share 10.32 12.01
-
8/8/2019 aarti iapm
43/60
31-Mar-05 31-Mar-06 31-Mar-07 31-Mar-08 31-Mar-09
265.27 271 307.09 335.85 409.69231.65 237.35 271.22 294.96 350.71
33.62 33.65 35.87 40.89 58.98
5.86 10.62 11.23 13.43 24.79
7.15 7.92 8.62 9.63 11.04
20.61 15.11 16.02 17.83 23.15
0.32 0.16 0.20 0.27 0.35
14.06 12.73 12.77 13.07 15.05
11.71 11.71 11.71 11.71 11.71
0.30 0.15 0.12 0.18 0.30
3.51 1.76 1.4 2.11 3.51
31-Mar-05 31-Mar-06 31-Mar-07 31-Mar-08 31-Mar-09
11.71 11.71 11.71 11.71 11.71
64.86 75.57 86.73 97.34 108.27
3.39 2.27 1.15 3.72 0.00
73.18 85.01 97.29 105.33 119.98
46.80 30.94 42.64 47.95 72.04
45.24 67.01 74.93 70.71 80.71
49.23 84.13 74.99 86.51 25.73
141.28 182.09 192.56 205.17 178.48
214.45 267.10 289.85 310.50 298.46
150.37 200.60 212.53 233.59 267.26
42.62 50.95 62.36 74.47 87.88
107.75 149.65 150.17 159.12 179.38
22.60 0.16 13.91 14.86 0.8
1.46 20.40 21.35 33.53 21.38
151.32 170.98 172.31 187.68 185.14
58.66 74.09 67.89 84.69 88.23
92.65 96.89 104.42 102.99 96.91
-
8/8/2019 aarti iapm
44/60
224.46 267.10 289.85 310.50 298.46
8 9
4795.06 7,204.25
7070.5 8,070.95
8651.2 2,572.65
19,256.36 20516.76 17,847.85
21,253.39 23359.01 26,725.92
5,095.16 6,236.45 7446.69 8,788.25
15,016.94 15912.33 17,937.66
2,260.06 Nil 1375.2 1466.9 64.42
3352.82 2,137.85
14,925.62 15,131.79 17,098.48 17,231.02 18767.555,547.41 6626.63 7,076.76
10,800.32 11,683.60 12140.92 11,436.96
83.1 93.11 102.47
10.85 10.90 11.17 12.85
-
8/8/2019 aarti iapm
45/60
31-Mar-10 projection based on
496.95 CAGR FOR LAST TEN YEARS422.91
74.04 CAGR FOR LAST TEN YEARS
16.70 ST YR INTEREST/ AVG. DEBT FOR LAST 2 YR
13.52
43.82
0.40 average of last five years
26.1
12.11 same as last year
0.50
6.05
31-Mar-10 projection based on
12.11 same as last year
134.34 future PAT and last yr reserves
5.36 average of last TEN yrs
141.09
64.08
75.54
38.02
177.64 last two yrs total liabilities
318.73
287.48 CAGR FOR LAST TEN YEARS
103.95
183.53
3.40 USED AS PLUG
21.38
200.32 same as last year
89.9 same as last year
110.42
(LAST YR DEP./ LAST YR NET FIXEDASSETS)* current yr net fixed assets
as a growing company expected dividendis expected to remain high and so taken as
last yr level of 50%
accumulated depriciation and Gross assetsof last yr
as per company's future plan 30, 35, and45 cr in coming 3 years
-
8/8/2019 aarti iapm
46/60
318.73
18,513.71
-
8/8/2019 aarti iapm
47/60
PROJECTED DA
formula applied 31-Mar-11 31-Mar-12
0.14 567.73 648.59
0.15 85.31 98.3
0.0938 16.68 16.69
15.62 15.62 18.04
53.01 63.57
0.28 0.28 0.28
38.37 46.00
12.11 12.11
0.50 0.5
equity capital * dividend% 6.05 6.05
PROJECTED DAT
31-Mar-11 31-Mar-12
12.11 12.11
AT this yr+ Reserves last yr-Div. paid this yr 166.66 206.61
2.09 2.09
equity cap+ reserves& surplus - misc exp 176.68 216.63
data not available
data not available
data not available
avg of last two yrs total liabilities 178.06 177.85
net worth + total borrowings = total liability 354.74 394.48
0.16 332.04 383.52
120.06 138.68
211.98 244.84
2.34 4.22
30.00 35.00
200.32 200.32
89.9 89.9
110.42 110.42
(accu. Dep last yr/gross fixed assets lastyr)* gross fixed assets this yr
-
8/8/2019 aarti iapm
48/60
net block + capital WIP+ Investments+ NWC 354.74 394.48
-
8/8/2019 aarti iapm
49/60
A
31-Mar-13
740.97
113.26
16.69
20.83
75.74
0.28
54.81
12.11
0.5
6.05
31-Mar-13
12.11
255.37
2.09
265.39
177.95
443.35
442.97
160.17
282.8
5.13
45.00
200.32
89.9
110.42
-
8/8/2019 aarti iapm
50/60
443.35
-
8/8/2019 aarti iapm
51/60
ROUGH SHEET
2006 2007
Gross Sales 271 307.09
Net Sales 244.8 276.3
Other Income 8.81 6.74
Value Of Output 252.06 270.01
Cost of Production 215.58 244.1
Selling Cost 8.17 9.87
PBIT 25.73 27.25
PBIDT 33.65 35.87
PBDT 23.03 24.64
PBT 15.11 16.02
PAT 12.73 12.77
CP 20.65 21.39
Revenue earnings in fore 78.63 93.13Revenue expenses in fore 73.33 91.09
Capital earnings in forex 0 0
Capital expenses in forex 0.42 0.72
Book Value (Unit Curr) 74.53 84.07
Market Capitalisation 103.69 72.6
CEPS 17.43 18.1
(annualised) (Unit Curr)
EPS (annualised) (Unit Cur 10.67 10.73
Dividend (annualised%) 15 12
Payout (%) 14.09 11.14
Cash Flow From Operating Acti 15.31 27.11
Cash Flow From Investing Acti -46.17 -24.17
Cash Flow From Financing Acti 28.3 -4.76
-
8/8/2019 aarti iapm
52/60
-
8/8/2019 aarti iapm
53/60
2008 2009 2010
335.85 409.69 496.95 ### ### ### ###
310.73 376.51 471.42 2,068.422,532.042,441.54 2,663.72
1.84 0.17 0.45 831.35 865.93 549.67 385.82
319.97 369.56 467.66 389.24 437.51 509.65 572.23
273.86 304.87 388.46 847.83 1,228.601,382.221,705.67
8.96 10.75 13.5 790.83 1,092.60 1,144.04 1,207.67
31.26 47.94 60.52 1,300.951,300.951,170.861,170.86
40.89 58.98 74.04 15 10 15 30
27.46 34.19 57.34 195.14 130.09 175.63 351.26
17.83 23.15 43.82 3,410.964,420.194,675.715,477.57
13.07 15.05 26.1 22.6 15.76 8.92 451.97
22.7 26.09 39.62 4,689.31 5,705.38 5,837.65 6,196.46
109.3 139.36 152.7984 96.82 116.22 2,840.73 2,276.89 2,662.98 3,081.23
0 0 0 3,178.58 3,938.03 4,463.71 5,368.61
0.06 1.34 0.63 399.82 693.09 1,228.44 2,231.35
93.13 102.46 120.15 6,419.136,908.018,355.13 ###
61.42 44.5 123.7 7,857.90 9,276.53 ### ###
19.08 21.77 32.98 2,107.272,542.323,009.423,581.36
5,750.636,734.21 7,194.73 8,205.86
10.85 12.34 21.43 302.59 nil nil 617.92
18 30 50 116.99 128.87 132.55 31.44
16.6 24.29 24.1 8,044.98 8,742.51 ### ###
30.95 60.86 43.47 3,106.762,992.213,448.376,152.53
-31.78 -6.45 -23.37 4,938.225,750.307,250.158,773.09
-0.68 -54.34 -19.15 36.05 43.86 49.86 52.92
-
8/8/2019 aarti iapm
54/60
10.77 10.22 17.39
7.98 -4.95 6.72
9.9 14.41 7.57
9.37 21.99 21.312.46 21.17 25.21
16.83 10.72 26.29
14.79 -2.14 5.72
13.99 44.24 25.53
11.44 24.51 67.71
14.72 53.36 26.24
11.3 29.84 89.29
2.35 15.15 73.42
6.12 14.93 51.86
17.36 27.5 9.64-7.78 15.26 20.04
-15.4 -27.55 177.98
-
8/8/2019 aarti iapm
55/60
###
3,362.00
586.08
714.7
2,061.22
1,406.22
1,170.86
30
351.26
6,486.07
339.32
7,317.61
4,680.16
4,524.31
4,923.25
###
###
4,262.30
###
2,260.06
145.7
###
5,866.42
9,265.37
62.5
-
8/8/2019 aarti iapm
56/60
-
8/8/2019 aarti iapm
57/60
cash flow statement projection
1) 2005 2006
A) Net Profit before Tax 15.11
B) depriciation 7.92
C) interest paid 10.62
NWC 92.65 96.89D) LESS: Incremental WC 4.24
E) LESS: tax paid -2.38
F) -12.15
14.88
2)
-45.75
3) 28.32
-2.56
8.52
5.96
OTHERS( LIKE exchange rateloss/gain, inerest recvd, exp
amortized etc)Activities
Net Cash (used in)/from
investing ActivitiesNet Cash (used in)/fromFinancing Activities
Net (decrease)/increase InCash and Cash Equivalents
EquivalentsEquivalents
-
8/8/2019 aarti iapm
58/60
2007 2008 2009 2010 2011 E
16.02 17.83 23.15 43.82 53.01 FROM PROFORMA
8.62 9.63 11.04 13.52 15.62 FROM PROFORMA
11.23 13.43 24.79 16.70 16.7 FROM PROFORMA
104.42 102.99 96.91 110.42 110.42 FROM PROFORMA7.53 -1.43 -6.08 13.51 0.00 FROM PROFORMA
-3.25 -4.76 -8.1 -17.72 -21.44 FROM PROFORMA
1.61 -12.42 3.89 0.66 -3.68
26.70 25.14 60.85 43.47 60.21
-24.17 -31.78 -6.45 -23.37-23.37
AST YEAR FIGURE
-4.36 5.13 -54.33 -19.15 -19.15 LAST YEAR FIGURE
-1.83 -1.51 0.07 0.95 17.69
5.97 4.14 2.63 2.7 3.65
4.14 2.63 2.7 3.65 21.34
COMPANY'S CASHFLOWSTATEMENT
-
8/8/2019 aarti iapm
59/60
CASH FLOW STATEMENT
1) 2005 2006 2007 2008
A) Net Profit before Tax 15.11 16.02 17.83
B) depriciation 7.92 8.62 9.63
C) interest paid 10.62 11.23 13.43
NWC 92.65 96.89 104.42 102.99D) LESS: Incremental WC 4.24 7.53 -1.43
E) LESS: tax paid -2.38 -3.25 -4.76
F) -12.15 1.61 -12.42
14.88 26.70 25.14
2)
-45.75 -24.17 -31.78
3) 28.32 -4.36 5.13
-2.56 -1.83 -1.51
8.52 5.97 4.14
Closing Cash & Cash Equivalents 5.96 4.14 2.63
OTHERS( LIKE exchange rateloss/gain, inerest recvd, exp
amortized etc)Activities
Net Cash (used in)/frominvesting Activities
Net Cash (used in)/fromFinancing Activities
Net (decrease)/increase In Cashand Cash Equivalents
Equivalents
-
8/8/2019 aarti iapm
60/60
2009 2010 2011 E
23.15 43.82 53.01 FROM PROFORMA
11.04 13.52 15.62 FROM PROFORMA
24.79 16.70 16.7 FROM PROFORMA
96.91 110.42 110.42 FROM PROFORMA-6.08 13.51 0.00 FROM PROFORMA
-8.1 -17.72 -21.44 FROM PROFORMA
3.89 0.66 -3.68 COMPANY'S CASH FLOW STATEMENT
60.85 43.47 60.21
-6.45 -23.37 -23.37 LAST YEAR FIGURE
-54.33 -19.15 -19.15 LAST YEAR FIGURE
0.07 0.95 17.69
2.63 2.7 3.65
2.7 3.65 21.34